Magnitude of progression-free survival (PFS) improvement and treatment (Tx) duration in metastatic colorectal cancer (mCRC) for bevacizumab (BV) in combination with oxaliplatin-containing regimens: An analysis of two phase III studies Meeting Abstract
| Authors: | Giantonio, B. J.; Meropol, N. J.; Catalano, P. J.; Ng, V.; Oliver, R.; Sirzen, F.; Leonard, S.; Cassidy, J.; Benson, A. B. |
| Abstract Title: | Magnitude of progression-free survival (PFS) improvement and treatment (Tx) duration in metastatic colorectal cancer (mCRC) for bevacizumab (BV) in combination with oxaliplatin-containing regimens: An analysis of two phase III studies |
| Meeting Title: | 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 25 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2007 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2007-06-20 |
| Start Page: | 181s |
| Language: | English |
| ACCESSION: | WOS:000455043700727 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2007.25.18_suppl.4073 |
| Notes: | Meeting Abstract: 4073 -- Source: Wos |
